Published in J Chromatogr B Biomed Sci Appl on December 19, 1997
Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers. Antimicrob Agents Chemother (1998) 1.60
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients. Antimicrob Agents Chemother (2003) 1.31
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients. Antimicrob Agents Chemother (2005) 1.30
Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. Br J Clin Pharmacol (1998) 1.27
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients. Antimicrob Agents Chemother (2004) 1.16
Effect of fluoxetine on pharmacokinetics of ritonavir. Antimicrob Agents Chemother (1998) 1.13
Kinetics of antiviral activity and intracellular pharmacokinetics of human immunodeficiency virus type 1 protease inhibitors in tissue culture. Antimicrob Agents Chemother (1999) 1.02
Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers. Eur J Clin Pharmacol (2005) 0.81
Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1998) 0.78
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study. PLoS One (2012) 0.78
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2001) 0.77
Simple, Rapid and Validated LC Determination of Lopinavir in Rat Plasma and its Application in Pharmacokinetic Studies. Sci Pharm (2011) 0.75
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother (1986) 4.51
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci U S A (1995) 3.18
Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ (1990) 2.70
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrob Agents Chemother (1997) 2.57
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease. Antimicrob Agents Chemother (1998) 2.23
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler (2006) 1.95
Biosynthesis of the pigments of life: formation of the macrocycle. Nature (1980) 1.86
Biosynthesis of porphyrins and related macrocycles. Part 10. Vitamin B12: biochemical derivation of cobyrinic acid from uroporphyrinogen III. Studies with corresponding ring c methyl heptacarboxylic prophyrinogen, and proof of seven intact methyl transfers. J Chem Soc Perkin 1 (1977) 1.69
Occurrence of Cryptosporidium oocysts in fecal samples submitted for routine microbiological examination. J Clin Microbiol (1985) 1.57
Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med (2006) 1.52
Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis. Intensive Care Med (2013) 1.46
Oral acyclovir for chickenpox. Cutis (1991) 1.40
Fertility desires and fertility: hers, his, and theirs. Demography (1990) 1.40
Carcinoma of the colon associated with systemic sclerosis. N Y State J Med (1990) 1.39
Identification of primary HIV-1C infection in Botswana. AIDS Care (2008) 1.29
Amyotrophic lateral sclerosis severity scale. Neuroepidemiology (1989) 1.21
Immunological features of idiopathic Addison's disease: characterization of the adrenocortical antigens. Clin Exp Immunol (1968) 1.19
Purification of porphobilinogen deaminase from Euglena gracilis and studies of its kinetics. Biochem J (1981) 1.15
Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care (2000) 1.14
Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. Blood Coagul Fibrinolysis (2002) 1.11
A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. J Med Chem (1996) 1.09
Susceptibility testing of macrolide antibiotics against Haemophilus influenzae and correlation of in vitro results with in vivo efficacy in a mouse septicemia model. Antimicrob Agents Chemother (1987) 1.08
A cluster of Legionnaires' disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008-2009. Euro Surveill (2010) 1.07
Autophagy is altered in skeletal and cardiac muscle of spontaneously hypertensive rats. Acta Physiol (Oxf) (2013) 1.03
Radiation exposure to children during cardiac catheterization. Br J Radiol (1997) 1.02
Biosynthesis of porphyrins and related macrocycles. Part VI. Nature of the rearrangement process leading to the natural type III porphyrins. J Chem Soc Perkin 1 (1976) 1.01
Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J Med Chem (1998) 0.97
CANCER RESEARCH AND THE SCIENTIFIC METHOD. Science (1931) 0.97
Progressive resistance training did not improve walking but can improve muscle performance, quality of life and fatigue in adults with multiple sclerosis: a randomized controlled trial. Mult Scler (2011) 0.96
A fluorescence polarization assay for inhibitors of Hsp90. Anal Biochem (2006) 0.96
The action of natural and synthetic isomers of quisqualic acid at a well-defined glutamatergic synapse. Brain Res (1986) 0.92
The esophageal motility disorder of polymyositis. A prospective study. Arch Intern Med (1983) 0.92
If you build it, will they come? Using a mobile safety centre to disseminate safety information and products to low-income urban families. Inj Prev (2009) 0.91
Synthesis and antitumour activities of quinolone antineoplastic agents. Drugs Exp Clin Res (1992) 0.90
Lung volume reduction for emphysema and the Canadian Lung Volume Reduction Surgery (CLVR) Project. Can Respir J (1999) 0.89
A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg (2000) 0.88
Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol (1984) 0.86
Rheumatoid arthritis in a patient with sickle cell disease. J Rheumatol (1990) 0.84
Retrograde intramedullary nails with distal screws locked to the nail have higher fatigue strength than locking plates in the treatment of supracondylar femoral fractures: A cadaver-based laboratory investigation. Bone Joint J (2014) 0.83
Rhabdomyolysis after exercise. Postgrad Med (1993) 0.83
Biosynthesis of porphyrins and related macrocycles. Part 9. Biosynthesis of the corrin macrocycle of vitamin B12 including the sterochemistry of C-methylation in ring. J Chem Soc Perkin 1 (1977) 0.82
Biosynthesis of porphyrins and related macrocycles. Part VIII. Enzymic decarboxylation of uroporphyrinogen-II: Structure of an intermediate, phyriaporphyrinogen-III, and synthesis of the corresponding porphyrin and of two isomeric porphyrins. J Chem Soc Perkin 1 (1976) 0.81
Biosynthesis of porphyrins and corrins. Philos Trans R Soc Lond B Biol Sci (1976) 0.81
Response of uterine glucose-6-phosphate dehydrogenase isoenzymes to estrogen. Endocrinology (1972) 0.79
Towards consensus in the long-term management of relapse prevention in schizophrenia. Hum Psychopharmacol (2005) 0.78
Sites of synthesis of chromogranins A and B in the human brain. Neuropeptides (1992) 0.78
Biosynthesis of porphyrins and related macrocycles. Part V. Structural integrity of the type III porphyrinogen macrocycle in an active biological system; studies on the aromatisation of protoporphyrinogen-IX. J Chem Soc Perkin 1 (1976) 0.78
Seborrheic dermatitis in acquired immunodeficiency syndrome. Cutis (1991) 0.78
Homosexuals who are twins. A study of 46 probands. Br J Psychiatry (1992) 0.78
Alkaloid biosynthesis. 18. Biosynthesis of colchicine from the 1-phenethylisoquinoline system. J Chem Soc Perkin 1 (1972) 0.77
Does plugging unused combination screw holes improve the fatigue life of fixation with locking plates in comminuted supracondylar fractures of the femur? J Bone Joint Surg Br (2012) 0.77
Chronic recurrent multifocal osteomyelitis in adult women. N Y State J Med (1992) 0.77
Novel azacyclic ureas that are potent inhibitors of HIV-1 protease. Biochem Biophys Res Commun (1996) 0.76
Differential activation on fMRI of monozygotic twins discordant for AD. Neurology (2003) 0.76
Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis: comment on the article by Paul et al. Arthritis Care Res (2000) 0.75
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactams. Bioorg Med Chem Lett (2001) 0.75
A study of family practice in Wisconsin. J Fam Pract (1979) 0.75
Synthetic [5,5] trans-fused indane lactones as inhibitors of thrombin. Bioorg Med Chem Lett (1999) 0.75
The Preparation of Wet Ashed Tissues for Liquid Counting. Science (1952) 0.75
Biosynthesis of porphyrins and related macrocycles. IV. Synthesis of isomeric aminomethylpyrromethanes for biosynthetic study. J Chem Soc Perkin 1 (1974) 0.75
Universal ventilation laser tracheoscope. Ann Otol Rhinol Laryngol (1988) 0.75
Potent inhibitors of the HIV-1 protease with good oral bioavailabilities. Biochem Biophys Res Commun (1995) 0.75
Nucleotide radical oxidation and addition reactions with cellular radiosensitizers. Biochem Biophys Res Commun (1973) 0.75
Functional teams lead to Joint Commission success. J Nurs Care Qual (1997) 0.75
Biosynthesis of porphyrins and related macrocycles. I. Synthesis of 14C-labelled pyrromethanes. J Chem Soc Perkin 1 (1973) 0.75
The Atomic Processes of Disease. Can Med Assoc J (1926) 0.75
ADRENAL CORTEX EXTRACT AND CANCER. Science (1930) 0.75
Chemical screening tests for cellular radiosensitizers--nitrofurans. Int J Radiat Biol Relat Stud Phys Chem Med (1972) 0.75
Geriatrics in family practice. A comparison of data from Wisconsin and Virginia. Postgrad Med (1980) 0.75
Thrombin inhibitors based on [5,5] trans-fused indane lactams. Bioorg Med Chem Lett (1999) 0.75
The relation between physician and patient age in family practice. J Fam Pract (1976) 0.75
A new road.... Wash Nurse (1995) 0.75
Treating dysphagia. J Gerontol Nurs (1983) 0.75
Toradol and the risk of gastrointestinal complications in the elderly. J Am Geriatr Soc (1993) 0.75
Biosynthesis of porphyrins and related macrocycles. Part 13. Structure of the protoporphyrin isomer derived from coproporphyrinogen IV by the action of beef-liver coproporphyrinogenase: synthesis of protoporphyrin XIII. J Chem Soc Perkin 1 (1980) 0.75
A comparison of four holding devices for anchoring nasogastric tubes. J Neurosurg Nurs (1982) 0.75
Lichen planus in patients with rheumatoid arthritis treated with sulfasalazine. J Rheumatol (1995) 0.75
Design of dental surgeries in relation to instrument decontamination. J Hosp Infect (2010) 0.75
Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Bioorg Med Chem Lett (1998) 0.75
PUERPERAL GENERAL PERITONITIS: REPORT OF ELEVEN CASES. Ann Surg (1907) 0.75
Radiation chemical studies with nitrofurazone as related to its mechanism of radiosensitization. Radiat Res (1973) 0.75
Osteoarthritis and rheumatoid arthritis in elderly patients. Differentiation and treatment. Postgrad Med (1991) 0.75
"Is that ward report finished yet"? N Z Nurs J (1985) 0.75
An attitudinal objective: its measurement through the use of taxonomy II. J Med Educ (1967) 0.75
CELLULAR DIVISION IN RELATION TO CANCER. Science (1929) 0.75